BBJ selects 2025 Inno Fire nominees (by Harper Harwell for the Birmingham Business Journal)
The Birmingham Business Journal presents its nominees from Alabama’s startup ecosystem for the 2025 Inno Fire feature.
BBJ selects 2025 Inno Under 25 honorees (by Harper Harwell for the Birmingham Business Journal)
The Birmingham Business Journal showcases talented innovators under the age of twenty-five in its Inno Under 25 spotlight.
Behind the deal: How IllumiCare acquisition aims to lower health care costs (by Harper Harwell for the Birmingham Business Journal)
In an interview with the Birmingham Business Journal, G.T. LaBorde, the founder and CEO of IllumiCare, discusses how the company’s acquisition will help them change the healthcare system.
Bham company inks deal with Under Armour for major golf event (by Trevor Mickle for the Birmingham Business Journal)
Wunderpar, a golfing app that’s part of the metro-area-based Wunderfan brand, is partnering with Under Armour to sponsor The British Open.
Birmingham AI nonprofit appoints first director to lead expansion efforts by Harper Harwell for the Birmingham Business Journal)
Birmingham AI, a local nonprofit offering discussions about AI founded by Will Blackburn and Austin Senseman, appointed Birmingham native William Glass as their first director.
Fintech startup raises $3M in out-of-state funding (by Harper Harwell for the Birmingham Business Journal)
Occupi, a Birmingham-area startup offering payment solutions for property managers, recently closed an overesubscribed $3M seed round of funding from out-of-state investors.
Las Vegas startup secures partnerships with Birmingham entities (by Harper Harwell for the Birmingham Business Journal)
AloeVR, a Las Vegas-based startup providing a virtual reality program that helps children deal with their emotions, developed partnerships with Birmingham organizations during their time at the gener8tor Prosper HealthTech Accelerator.
Major pharmaceutical entity lead investor for metro startup funding round (by Harper Harwell for the Birmingham Business Journal)
Shilpa Medicare (NSE: SHILPAMED) invested in the ongoing Series A round of Birmingham’s Alveolus Bio. Alveolus Bio’s inhalable drug candidate, using their proprietary resMIT platform, will deliver safe, targeted, and natural bacteria directly to the lungs, addressing inflammation and lung injury, including that caused by COPD, the fourth leading cause of death in the United States.
The National Observer: Federal funding uncertainty may affect startups (by Joshua Mann for the Birmingham Business Journal)
According to Mary Vance of the Cleveland Business Journal, tech startups may be negatively impacted by the uncertainty surrounding federal research grants.
Viewpoint: Birmingham, let’s declare a jobs war (Don Erwin for the Birmingham Business Journal)
Guest writer Don Erwin discusses the reasons behind the lack of growth in the Birmingham metro area and how to best encourage economic development in Birmingham and its suburbs.